Oxygenation in acute exacerbation of interstitial lung disease:a nationwide survey

Acute exacerbation of interstitial lung disease (AE-ILD) may lead to acute respiratory failure with poor prognosis. Little is known about the optimal oxygenation strategy in this indication, in particular since the development of high-flow nasal oxygen therapy (HFNO). Therefore, we conducted a nationwide survey among respiratory and intensive care unit (ICU) physicians to assess their real-life practices. Between January and June 2024, physicians were questioned, using an online survey (11 questions), regarding the non-invasive oxygenation strategy they used in the management of patients with AE-ILD: face mask (FM), HFNO, continuous positive airway pressure (CPAP) or non-invasive ventilation (NIV). The response rate was 119/270 (44.1%), including 59.5% of ICU and 40.5% of respiratory physicians.=.